Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Hungary Bill notified to include cannabinoids on narcotics list ...
  • Panama Bill regulating hemp approved in first debate ...
  • Germany First cannabis club in Lower Saxony harvests 200 plants ...
  • Belgium List of notified herbal products for smoking updated ...
  • Lithuania Seimas approves amendments to Fibre Hemp Law ...
  • Uruguay More potent cannabis variant sold in pharmacies from today ...
  • Italy EC assessing compliance of bill restricting hemp to industrial uses ...
  • Europe Council adopts new CLP regulation ...
  • France No plans proposed to extend medical cannabis experiment ...
  • California - United States Court rejects industry attempt to block new hemp regulation ...
  • Germany Majority of survey respondents think cannabis legalisation was wrong ...
  • World International E-waste Day raises awareness of e-waste ...
View all
News analysis

CBD-Intel business news in brief, 19th-23rd August 2019

Written by CannIntelligence | 26th August 2019

Items from China, Thailand, Colombia, Israel, the US, Canada, UK and Ireland include news of the political leader’s son who is planning to open a hemp store, with dad’s blessing ...

CBD-Intel regulatory news in brief, 19th-23rd August 2019

Written by CannIntelligence | 26th August 2019

Austrian and German police policy, local THC decision in Italy, Slovakian de-scheduling, Croatian proposals, US federal and state rulings and Israeli priorities come under the regulatory spotlight ...

CBD-Intel regulatory news in brief

Written by CannIntelligence | 19th August 2019

CBD-Intel’s regular round-up of regulatory news features items from the US, Mexico, Germany, Italy, Spain, Thailand, Trinidad and Tobago, and the self-governing UK dependency of Jersey ...

New clinical trial investigates CBD-infused oral health products

Written by Lorraine Mullaney | 19th August 2019

A new clinical trial is investigating the efficacy of CBD-infused mouthwashes and toothpaste when used to treat gum disease. The randomised controlled clinical trial is a collaboration between Australian medicinal cannabis business Impression Healthcare and...

US Gallup poll reveals CBD usage and awareness parallels

Written by Freddie Dawson | 15th August 2019

A new Gallup poll has found that usage of CBD products among American consumer almost exactly mirrors awareness. The poll found that around 14% of those surveyed used CBD while 50% did not, though they...

CBD-Intel regulatory news in brief

Written by CannIntelligence | 12th August 2019

CBD-Intel’s regular round-up of regulatory news features items from Germany, Switzerland, Belgium, the UK, and the...

A hole in one – will sports and CBD continue to entwine?

Written by Lorraine Mullaney | 8th August 2019

The sports world is becoming increasingly enamoured with CBD. US professional golfers have become the latest sporting personalities to endorse CBD products, including 2009 US Open winner Lucas Glover. Will CBD continue to wind its way...

The future of CBD-infused beverages is bright

Written by CannIntelligence | 7th August 2019

Interest and investment in CBD beverages continues to grow despite some criticism of cannabis drinks in general; so far, the industry has struggled to get oil-based cannabinoids into water-based beverages without issues. But all of...

CBD-Intel regulatory news in brief

Written by CannIntelligence | 5th August 2019

CBD-Intel’s regular round-up of regulatory news features items from Germany, Italy, France, the Netherlands, Spain, Luxembourg, Canada, the US and South Africa ...

MHRA enforces CBD rules with British store

Written by CannIntelligence | 1st August 2019

A British shop specialising in hemp-related products says it has been told to remove some information from its website by the organisation responsible for regulating medicinal health...

Epidyolex takes huge step toward EU licensing

Written by CannIntelligence | 31st July 2019

A European review committee has recommended that British company GW Pharmaceuticals’ Epidyolex (known as Epidiolex in the US) be licensed as a medicine in the European...

US urgently needs hemp regulations, Senate is told

Written by CannIntelligence | 30th July 2019

Rising demand for hemp products could soon make it an important cash crop for America but both industry and regulators must change to meet evolving demands and...

CBD-Intel regulatory news in brief

Written by CannIntelligence | 24th July 2019

CBD-Intel brings you regulatory updates and snippets from the US, UK, Italy, Germany and Belgium ...

CBD-Intel regulatory news in brief

Written by CannIntelligence | 22nd July 2019

CBD-Intel’s regular round-up of regulatory snippets features news from the US, Europe and China ...

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.